Adaptin Bio, Inc. Operating Cash Flow
Adaptin Bio, Inc. (APTN) reported Operating Cash Flow of -$1.05 million for the 6-month period ending 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-28
- Adaptin Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$450.16K.
- Adaptin Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$596.30K.
- Adaptin Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$702.88K, a 723.93% decline year-over-year.
- Adaptin Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$772.43K.
- Adaptin Bio, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$81.03K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 10 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$450.16K derived: S-1 6 month − POS AM 3 month · filed 2026-08-28 | -$1.05M S-1 · filed 2026-08-28 | -$1.75M derived: sum of 3 quarters · filed 2026-08-28 | -$2.52M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2026-03-31 | -$596.30K POS AM · filed 2026-07-21 | -$1.30M derived: sum of 2 quarters · filed 2026-08-28 | -$2.07M derived: sum of 3 quarters · filed 2026-08-28 | -$3.09M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | -$702.88K derived: S-1 12 month − 10-Q 9 month · filed 2026-08-28 | -$1.48M derived: sum of 2 quarters · filed 2026-08-28 | -$2.50M derived: sum of 3 quarters · filed 2026-08-28 | -$4.78M S-1 · filed 2026-08-28 | ||||
| 2025-09-30 | -$772.43K derived: 10-Q 9 month − S-1 6 month · filed 2025-11-14 | -$1.80M derived: sum of 2 quarters · filed 2026-08-28 | -$4.08M 10-Q · filed 2025-11-14 | -$3.96M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-06-30 | -$1.02M derived: S-1 6 month − POS AM 3 month · filed 2026-08-28 | -$3.30M S-1 · filed 2026-08-28 | -$3.19M derived: sum of 3 quarters · filed 2026-08-28 | -$3.66M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-03-31 | -$2.28M POS AM · filed 2026-07-21 | -$2.17M derived: sum of 2 quarters · filed 2026-08-28 | -$2.64M derived: sum of 3 quarters · filed 2026-08-28 | -$2.84M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | $112.65K derived: S-1 12 month − 10-Q 9 month · filed 2026-08-28 | -$355.76K derived: sum of 2 quarters · filed 2026-08-28 | -$559.59K derived: sum of 3 quarters · filed 2026-08-28 | -$649.28K S-1 · filed 2026-08-28 | -$181.54K 10-K · filed 2025-04-15 | |||
| 2024-09-30 | -$468.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$672.24K derived: sum of 2 quarters · filed 2025-11-14 | -$761.94K 10-Q · filed 2025-11-14 | -$56.60K 10-Q · filed 2024-11-14 | -$820.28K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | -$203.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$293.52K 10-Q · filed 2025-08-14 | -$31.41K 10-Q · filed 2024-08-14 | -$351.87K derived: sum of 3 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$89.69K 10-Q · filed 2025-05-15 | -$148.04K derived: sum of 2 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | -$58.35K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$81.03K 10-K · filed 2025-04-15 | ||||||
| 2023-09-30 | -$22.69K 10-Q · filed 2024-11-14 | |||||||
| 2022-12-31 | -$304.00 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | -$304.00 10-Q · filed 2023-11-14 |